Form 8-K - Current report:
SEC Accession No. 0001193125-21-037280
Filing Date
2021-02-11
Accepted
2021-02-11 07:00:28
Documents
5
Period of Report
2021-02-08
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d95909d8k.htm 8-K 22694
2 EX-3.1 d95909dex31.htm EX-3.1 26566
3 EX-3.2 d95909dex32.htm EX-3.2 111195
4 EX-99.1 d95909dex991.htm EX-99.1 7313
5 GRAPHIC g95909g02j80.jpg GRAPHIC 2923
  Complete submission text file 0001193125-21-037280.txt   173109
Mailing Address 620 PROFESSIONAL DRIVE GAITHERSBURG MD 20879
Business Address 620 PROFESSIONAL DRIVE GAITHERSBURG MD 20879 (240) 243-8000
Sensei Biotherapeutics, Inc. (Filer) CIK: 0001829802 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39980 | Film No.: 21616634
SIC: 2834 Pharmaceutical Preparations